Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: dirven h. Biomed Pharmacother. 2024 May;174:116530. doi: 10.1016/j.biopha.2024.116530. Epub 2024 Apr 3. Biomed Pharmacother. 2024. PMID: 38574623 Free article. Review.
Immune cell profiles associated with human exposure to perfluorinated compounds (PFAS) suggest changes in natural killer, T helper, and T cytotoxic cell subpopulations.
Tursi AR, Lindeman B, Kristoffersen AB, Hjertholm H, Bronder E, Andreassen M, Husøy T, Dirven H, Andorf S, Nygaard UC. Tursi AR, et al. Among authors: dirven h. Environ Res. 2024 Sep 1;256:119221. doi: 10.1016/j.envres.2024.119221. Epub 2024 May 23. Environ Res. 2024. PMID: 38795951 Free article.
Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: dirven h. Biomed Pharmacother. 2024 Jun;175:116813. doi: 10.1016/j.biopha.2024.116813. Epub 2024 May 24. Biomed Pharmacother. 2024. PMID: 38789350 Free article. No abstract available.
A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health.
Mhaouty-Kodja S, Zalko D, Tait S, Testai E, Viguié C, Corsini E, Grova N, Buratti FM, Cabaton NJ, Coppola L, De la Vieja A, Dusinska M, El Yamani N, Galbiati V, Iglesias-Hernández P, Kohl Y, Maddalon A, Marcon F, Naulé L, Rundén-Pran E, Salani F, Santori N, Torres-Ruiz M, Turner JD, Adamovsky O, Aiello-Holden K, Dirven H, Louro H, Silva MJ. Mhaouty-Kodja S, et al. Among authors: dirven h. Crit Rev Toxicol. 2024 Oct 22:1-58. doi: 10.1080/10408444.2024.2388712. Online ahead of print. Crit Rev Toxicol. 2024. PMID: 39436315 Review.
Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment.
Reale E, Zare Jeddi M, Paini A, Connolly A, Duca R, Cubadda F, Benfenati E, Bessems J, S Galea K, Dirven H, Santonen T, M Koch H, Jones K, Sams C, Viegas S, Kyriaki M, Campisi L, David A, Antignac JP, B Hopf N. Reale E, et al. Among authors: dirven h. Environ Int. 2024 Feb;184:108474. doi: 10.1016/j.envint.2024.108474. Epub 2024 Feb 8. Environ Int. 2024. PMID: 38350256 Free article.
71 results